Terumo Pharmaceutical Solutions Division

What Terumo Pharmaceutical Solutions Division does

Terumo Pharmaceutical Solutions Division provides devices and services for parenteral drug delivery. The division offers injection and infusion products such as hypodermic needles, pen injector needles, and Surflo winged infusion sets, as well as primary packaging including PLAJEX ready-to-fill polymer syringes. It supplies these components and systems for use with vaccines, biologics, and other injectable formulations. Terumo Pharmaceutical Solutions Division also delivers contract development and manufacturing services for sterile injectables, covering combination device design, formulation support, and commercial manufacturing. Its engineering and development teams support pharmaceutical and medical device manufacturers with design, materials compatibility analysis, downstream manufacturing optimization, regulatory data, kitting, and component assembly. The division focuses on collaborating with pharmaceutical companies from early development through commercialization to support safe and efficient drug delivery.

Name

Terumo Pharmaceutical Solutions Division

Legal name

Terumo Corporation

Website

https://www.terumopharmaceuticalsolutions.com

Company type

Public

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Terumo Pharmaceutical Solutions Division provides parenteral drug delivery devices, primary packaging, and CDMO services for pharmaceutical/

Ownership category

akta.pro rank

Product category

Pharmaceutical Packaging and CDMO Services

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (3391)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)

akta.pro secondary industries

Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)

Keywords

• Prefilled syringes
• Parenteral drug delivery
• Aseptic fill-finish
• Pharmaceutical CDMO services
• Injection needles

Headquarters

HQ city

Leuven

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Infrastructure, Marketing or Sales, Supply Chain, Operations, Technology or R&D, Personnel

Revenue model

1. CDMO Services: Integrated Contract Development and Manufacturing Organization services including sterile fill-finish of injectable drug products in polymer prefilled syringes and glass vials, drug formulation development, device assembly, and regulatory support from clinical to commercial phases
2. Medical Devices and Primary Packaging: Sale of high-quality parenteral drug delivery devices including prefillable syringes, injection needles, safety needles, disposable syringes, infusion sets, and drug delivery devices to pharmaceutical and biotechnology companies

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Terumo Pharmaceutical Solutions Division manufactures polymer prefillable syringes (PLAJEX™ platform), injection needles, safety needles, infusion sets, and disposable syringes, while simultaneously operating an integrated Contract Development and Manufacturing Organization (CDMO) offering aseptic fill-finish, drug product formulation development, device assembly, labelling and packaging, and regulatory support for pharmaceutical and biotechnology customers. The offering is built around proprietary i-coating™ silicone oil-free stopper technology and Cyclo Olefin Polymer syringe barrels, designed to preserve sensitive biotherapeutics and provide a single-source path from clinical development through commercial manufacturing of sterile injectable products.

Product overview

Terumo Pharmaceutical Solutions Division is a Contract Development and Manufacturing Organization (CDMO) and medical device manufacturer offering an integrated portfolio of parenteral drug delivery solutions. The core product line centers on PLAJEX™ polymer prefillable syringes (with Luer Lock, tapered needle, staked needle, and 0.5mL silicone oil-free configurations) featuring proprietary i-coating™ technology. Supporting product categories include injection needles (K-Pack™II, Nanopass™ 32.5G/34G, Neolus™, Injection Filter Needle), safety needles (SurGuard™3), drug delivery devices (Immucise™ Intradermal Injection System), infusion sets (Surflo™ Winged with/without Surshield™), and disposable syringes. The integrated CDMO service offering encompasses primary container manufacturing, drug product formulation development, aseptic fill-finish services, drug delivery device assembly, labelling/packaging, and regulatory support—all designed to provide pharmaceutical and biotech customers with a single-source solution from early-phase development through commercial manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• PLAJEX: Terumo's proprietary platform of polymer prefillable syringes (PFS) made from Cyclo Olefin Polymer (COP). Includes Luer Lock, Staked Needle, and Tapered Needle configurations, with optional i-coating technology for silicone oil-free solutions.
• PLAJEX i-coating
• Immucise
• Nanopass
• SurGuard
• Surflo
• Surshield
• K-Pack
• Neolus
• T-Sharp
• INFINO

Products and services

• PLAJEX™ Ready-to-Fill Polymer Syringes with Luer Lock Ready-to-fill polymer syringes with integrated molded Luer Lock mechanism compliant with ISO 80369-7, featuring advanced Cyclo Olefin Polymer (COP) barrel with excellent strength and clarity. Optional i-coating™ stopper technology enables silicone oil-free configuration for sensitive biotherapeutics. Designed for pharmaceutical and biotechnology customers requiring parenteral primary packaging.
• PLAJEX™ Ready-to-Fill Polymer Syringes with Tapered Needle Ready-to-fill polymer syringes with proprietary tapered needle technology providing reduced injection force for highly viscous formulations. Features COP barrel and i-coating™ silicone oil-free stopper technology designed to preserve sensitive biotherapeutics. Targeted at pharmaceutical manufacturers developing highly viscous parenteral formulations.
• PLAJEX™ 0.5 mL Luer Lock Silicone Oil-free Syringes Low-dose polymer prefillable syringes designed for ophthalmic injections and other low-volume applications. Features i-coating™ stopper technology eliminating silicone oil to avoid droplet formation, supporting USP <789> compliance for subvisible particle levels. Aimed at ophthalmic pharmaceutical manufacturers.
• PLAJEX™ Ready-to-Fill Polymer Syringes with Staked Needle Ready-to-fill polymer syringes with integrated staked needle providing lower protein interactions. Features COP barrel and proprietary i-coating™ stopper technology enabling silicone oil-free solution for preserving sensitive biotherapeutics. Designed for pharmaceutical and biotechnology customers.
• K-Pack™II Needles Hypodermic injection needles featuring T-Sharp™ lancet technology with silicon coating, available in thin, extra-thin, and ultra-thin-wall cannulas. Designed for SC, IM, and IV injections with automated handling capabilities. Sold to pharmaceutical manufacturers and healthcare providers.
• Nanopass™ 32.5G Needle Reduced diameter thin-wall pen needle with asymmetric lancet bevel designed to cut skin rather than pierce it, reducing pain during insertion. Features 4mm, 6mm, and 8mm length options for pen injector applications. Targeted at pen injector manufacturers and pharmaceutical companies.
• Nanopass™ 34G Needle World's thinnest double-tapered 34G pen needle with 22% thinner design than 32G alternatives. Features asymmetric bevel for reduced pain and better flow, designed for SC injections of insulin and human growth hormones. Targeted at diabetes and growth hormone pharmaceutical manufacturers.
• Neolus™ Needles High-performance ISO compliant single-use stainless steel injection needles with lancet point design. Features silicone coating and color masterbatch hubs for easy diameter identification. Suitable for SC, IM, and IV injections. Sold to pharmaceutical manufacturers and healthcare providers.
• Terumo Injection Filter Needle Hypodermic and intravitreal injection needle with integrated 5μm polyamide mesh filter designed to prevent particles from being injected. Developed as part of INFINO™ program for safe injections into sensitive areas including the vitreous. Targeted at pharmaceutical manufacturers and ophthalmic specialists.
• SurGuard™3 Safety Hypodermic Needles Safety hypodermic needles with three-way activation hinged safety sheath (hard surface, finger, or thumb). Features T-Sharp™ lancet point technology and is available in 18G to 30G gauge options for needlestick protection. Sold to pharmaceutical manufacturers and healthcare providers for needlestick injury prevention.
• Immucise™ Intradermal Injection System Intradermal injection system designed to deliver vaccines and approved drugs to the dermal layer of skin for improved immune response. Features 33G stainless steel needle with limiter ring for perpendicular insertion into deltoid region. Targeted at vaccine manufacturers and public health programs.
• Surflo™ Winged Infusion Set Winged infusion sets with color-coded wings for easy needle gauge identification. Features T-Sharp™ lancet technology, flexible kink-resistant tubing, and slightly angled wings for less pressure on blood vessels during IV injections. Sold to pharmaceutical manufacturers and healthcare providers.
• Surflo™ Winged Infusion Set with Surshield™ Winged infusion set with integrated Surshield™ needle protection feature that minimizes accidental needlestick injuries. Features color-coded wings, optional 20-micron filter, and microbore tubing for reduced dead space volume. Sold to pharmaceutical manufacturers and healthcare providers.
• Terumo Syringes (3-part) Sterile single-use 3-part syringes with Luer Slip or Luer Lock connectors. Features leak-proof design, accurate expelled volume control per EN ISO 7886-1, and evenly lubricated gaskets for comfortable injections. Sold to pharmaceutical manufacturers and healthcare providers.
• CDMO Primary Container Manufacturing Contract manufacturing of PLAJEX™ polymer prefillable syringes using advanced Cyclo Olefin Polymer (COP) resin with high-pressure injection molding. Includes silicone oil-free and tungsten-free options with reliable supply chain. Offered to pharmaceutical and biotechnology companies as a CDMO engagement.
• CDMO Drug Product Development Early phase parenteral formulation development services including sterile injectable formulation optimization, prefilled syringe material compatibility studies, and co-development of primary container specifications. Supports mAbs, proteins, peptides, and viscous formulations up to 120 cP. Offered to pharmaceutical and biotechnology companies.
• CDMO Aseptic Fill-Finish GMP aseptic filling of polymer prefillable syringes (PFS) and glass vials (liquid or lyophilized) under ISO Class 5/Grade A isolator environments. Includes automated camera inspection for particulate and defect detection. Offered to pharmaceutical and biotechnology companies at clinical and commercial scales.
• CDMO Drug Delivery Device Assembly GMP assembly services for autoinjectors, safety devices, and add-on components using manual or automated robotic assembly processes from clinical to commercial scales. Offered to pharmaceutical and biotechnology companies.
• CDMO Labelling, Packaging and Palletizing End-to-end labelling services for primary packaging or drug delivery devices such as autoinjectors, including secondary packaging, blister packaging, and palletizing for global distribution. Offered to pharmaceutical and biotechnology companies.
• CDMO Regulatory Support Comprehensive regulatory support spanning preclinical to commercial phases with expertise in FDA, EMA, PMDA, and ICH guidelines. Includes CMC section preparation, stability studies, and technology transfer oversight. Offered to pharmaceutical and biotechnology companies.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• West Pharmaceutical Services: West Pharmaceutical Services is the closest direct competitor in elastomer and polymer primary packaging components for injectable drug products, including prefillable syringe components. Both companies compete in primary container design and integrated delivery solutions for biologics and sterile injectables.
• Stevanato Group: Stevanato Group offers pharmaceutical containment solutions including glass vials, syringes, and integrated drug delivery systems, with a growing CDMO presence. Direct overlap with Terumo in prefillable syringe technology and aseptic fill-finish services for injectables.
• Gerresheimer AG: Gerresheimer manufactures primary packaging for pharmaceuticals (glass and plastic containers, syringes, vials) and provides solutions for injectable drug delivery. Directly comparable in primary packaging for sterile injectables, though Terumo's polymer focus differentiates.
• SCHOTT Pharma: SCHOTT Pharma is a leading manufacturer of pharmaceutical glass packaging including vials, syringes, and ampoules for injectables. Both companies serve the same pharmaceutical customer base for primary containment of sterile injectable products, though Terumo focuses on polymer PFS.
• Catalent, Inc. Catalent is one of the largest CDMOs globally with significant sterile injectable fill-finish capacity. Direct competitor in aseptic CDMO services for injectables, including prefilled syringe and vial filling, with broader modality coverage and larger commercial scale than Terumo Pharmaceutical Solutions.
• Aptar Pharma: Aptar Pharma provides drug delivery solutions including injectable elastomer components, prefilled syringe components, and device assembly for injectables. Direct peer in primary packaging components and integrated drug delivery device assembly for sterile injectables.
• Ypsomed Holding AG: Ypsomed develops and manufactures injection systems including pen needles and autoinjectors for self-administration. Direct peer in pen needle and injectable drug delivery device categories, particularly competing with Terumo's Nanopass™ pen needle platform.
• Owen Mumford Ltd: Owen Mumford manufactures injection devices including safety needles, pen needles, and autoinjectors for pharmaceutical partners. Direct peer in injection drug delivery devices and safety needle technologies, serving overlapping pharmaceutical and biotech customers.

Broad incumbents

• Becton, Dickinson and Company (BD): BD is a broad medical device incumbent with a large prefilled syringe, injection needle, and drug delivery portfolio. While BD competes in many of Terumo's product categories (PFS, safety needles), it operates across a much wider medical device portfolio rather than specializing in pharma CDMO services.
• Lonza Group AG: Lonza is a major CDMO with sterile fill-finish and biologics manufacturing services that compete with Terumo's offerings. While overlapping in aseptic CDMO for injectables, Lonza has a much broader CDMO portfolio spanning small molecules, biologics, and cell/gene therapy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/terumo-pharmaceutical-solutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Terumo Pharmaceutical Solutions Division